You are here

  • Home
  • Archive
  • Volume 11, Issue 5
  • Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade

Article metrics

Article menu
Case report
Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade

 

Online download statistics by month:

Online download statistics by month: May 2023 to August 2025

AbstractFullPdf
May 2023549562160
Jun 202318018034
Jul 202311611635
Aug 202312812942
Sep 2023979835
Oct 2023747428
Nov 20239810120
Dec 202311011123
Jan 20246262108
Feb 2024383829
Mar 2024646575
Apr 2024555432
May 2024393921
Jun 2024616025
Jul 2024525321
Aug 2024353413
Sep 2024414486
Oct 2024595991
Nov 2024575822
Dec 2024555624
Jan 2025727225
Feb 202514114120
Mar 2025727221
Apr 2025727227
May 2025484924
Jun 2025363616
Jul 2025110
Aug 2025110
Total241324371057